Surely this has just come down to patient believers buying...

Surely this has just come down to patient believers buying versus the impatient/unwilling to hold a falling stock/stop-lossed /"scared by market macros" investors now.

There has been no material changes to the value of ACL, nor the future potential of fondaparinux alone (as highlighted by the Arixtra sales), it's just that not everybody is prepared to, or able to, leave their money in the market.

Or some clever people may have been able to sell down some in the last few weeks and increase their position by buying them back now. I wish I was that good at timing the market but unfortunately if I sell out at 55c - hoping to buy back at 50c to increase my holding - the FDA approval almost definitely comes overnight and I'm never prepared to buy them again. I'm unwilling to take that gamble as it's cost me heavily before on other stocks.

With no other funds available, I put the remnants of last week's pay in to "top up" a little this morning.